Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MyMO appears to have been a private digital health company focused on improving patient access and health system utilization by automatically filling cancelled physician appointments with in-person and virtual visits. Public descriptions characterize it as an AI healthcare technology company with patented technology aimed at improving patient-physician interactions and continuity of care through integration with provider scheduling workflows and electronic health records. The company was founded in New York around 2015-2016 by Brad Peltz, with Fay Rotenberg also described publicly as a co-founder. Available third-party sources suggest the company is no longer active as an operating business, despite older company-profile sites still listing it as active.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MyMO.